About
CAN-BIND

Executive Committee

Sidney Kennedy, MD, FRCPC

Sidney Kennedy, MD, FRCPC

Principal Investigator

Site Lead, St. Michael’s Hospital & University Health Network (Toronto, Ontario)

Academic Appointment

  • Professor of Psychiatry, University of Toronto (Toronto, Ontario)
  • Arthur Sommer Rotenberg Chair in Suicide and Depression Studies, St. Michael’s Hospital (Toronto, ON)
  • Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital (Toronto, Ontario)
  • Scientist, Krembil Research Institute, University Health Network (Toronto, Ontario)

Expertise

  • Clinical Trials, New Drug Discovery, Neuroimaging, Biomarkers

More information

icon
Pierre Blier, MD, PhD

Pierre Blier, MD, PhD

Site Lead, University of Ottawa (Ottawa, Ontario)
icon

Faranak Farzan, PhD

EEG Platform Lead
icon
Benicio Frey, MD, PhD, FRCPC

Benicio N. Frey, MD, MSc, PhD

Site Lead, McMaster University and St. Joseph’s Hamilton Research (Hamilton, Ontario)
icon
Jane Foster, PhD  

Jane Foster, PhD

Co-Lead, Drug Discovery & Reverse Translation Platform
Co-Lead, Molecular Platform
Financial Manager
icon
Peter Giacobbe, MD, MSc, FRCPC

Peter Giacobbe, MD, MSc, FRCPC

Site Lead, Sunnybrook Research Institute (Toronto, Ontario)
icon

Raymond Lam, MD, FRCPC

Site Lead, University of British Columbia (Vancouver, British Columbia)
Co-Lead, Clinical Platform
icon

Francesco Leri, PhD

Site Lead, University of Guelph (Guelph, Ontario)
Co-Lead, Drug Discovery & Reverse Translation Platform
icon

Glenda MacQueen, MD, PhD, FRCPC

Site Lead, University of Calgary (Calgary, Alberta)
Co-Lead, Neuroimaging Platform
icon
Roumen Milev, MD, PhD, FRCPsych, FRCPC

Roumen Milev, MD, PhD, FRCPsych, FRCPC

Site Lead, Queen’s University (Kingston, Ontario)
Co-Lead, Clinical Platform
icon

Daniel Mueller, MD, PhD

Site Lead, Centre for Addiction and Mental Health (CAMH) (Toronto, Ontario)
icon
Sagar Parikh, MD

Sagar Parikh, MD

Lead, Knowledge Translation Platform
icon
Susan Rotzinger, PhD

Susan Rotzinger, PhD

Program Manager
icon

Stephen Strother, PhD

Co-Lead, Neuroimaging Platform
icon
Claudio Soares, MD, PhD, FRCPC, MBA

Claudio Soares, MD, PhD, FRCPC, MBA

Lead, Strategy & New Partnerships
Lead, M-health, Innovation and Technology Research Platform
icon

Gustavo Turecki, MD, PhD

Site Lead, McGill University
Co-Lead, Molecular Platform 
icon

Rudolf Uher, MD, PhD

Lead, Data Science Platform
icon

Featured

Depression in 2020: Biomarkers, Technologies and Novel Therapies

EVENT INFORMATION Date: Saturday, February 2, 2019 Time: 7:30am-4:00pm Location: Chelsea Hotel, 33 Gerrard St W, Toronto PROGRAM Conference Program...

learn more

2018 Autumn Newsletter

Our autumn newsletter is now available. Catch up on our latest research and outreach updates!

learn more

Event Summary: CHOICE-D Launch Event

On the evening of October 11, 2018, the Mood Disorders Association of Ontario (MDAO) hosted a launch event for The CHOICE-D Patient and Family Guide to Depression Treatment.

learn more

Brain Scans: More than Black and White

How is neuroimaging used in depression research? What does the CAN-BIND Neuroimaging team do?

learn more

Event Summary: World Suicide Prevention Day- In The Square

World Suicide Prevention Day (WSPD) is held on September 10th each year and is organized...

learn more

Recent Publication

Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report

Allen TA, et al., Psychological Medicine, 2018

learn more

CHOICE-D Depression Treatment Guide

Looking for information about depression treatments?

A free resource for patients and families is now available!

learn more